ANKZF1 knockdown inhibits glioblastoma progression by promoting intramitochondrial protein aggregation through mitoRQC
Cancer Letters · 2024
DOI: 10.1016/j.canlet.2024.216895 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Guangzhao Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, 21…. Hauptthemen laut MEDLINE: Disease Progression, Glioblastoma, Mice, Nude, Mitochondria. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 75 Literaturangaben.
Abstract (Originalsprache)
Protein homeostasis is fundamental to the development of tumors. Ribosome-associated quality-control (RQC) is able to add alanine and threonine to the stagnant polypeptide chain C-terminal (CAT-tail) when protein translation is hindered, while Ankyrin repeat and zinc-finger domain-containing-protein 1 (ANKZF1) can counteract the formation of the CAT-tail, preventing the aggregation of polypeptide chains. In particular, ANKZF1 plays an important role in maintaining mitochondrial protein homeostasis by mitochondrial RQC (mitoRQC) after translation stagnation of precursor proteins targeting mitochondria. However, the role of ANKZF1 in glioblastoma is unclear. Therefore, the current study was aimed to investigate the effects of ANKZF1 in glioblastoma cells and a nude mouse glioblastoma xenograft model. Here, we reported that knockdown of ANKZF1 in glioblastoma cells resulted in the accumulation of CAT-tail in mitochondria, leading to the activated mitochondrial unfolded protein response (UPRmt) and inhibits glioblastoma malignant progression. Excessive CAT-tail sequestered mitochondrial chaperones HSP60, mtHSP70 and proteases LONP1 as well as mitochondrial respiratory chain subunits ND1, Cytb, mtCO2 and ATP6, leading to mitochondrial oxidative phosphorylation dysfunction, membrane potential impairment, and mitochondrial apoptotic pathway activation. Our study highlights ANKZF1 as a valuable target for glioblastoma intervention and provides an innovative insight for the treatment of glioblastoma through the regulating of mitochondrial protein homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, 215006, China; Institute of Stroke Research, Soochow University, Suzhou,…
Zitieren
APA
Li, G., Wang, Z., Gao, B., Dai, K., Niu, X., Li, X., Wang, Y., Li, L., Wu, X., Li, H., Yu, Z., Wang, Z., & Chen, G. (2024). ANKZF1 knockdown inhibits glioblastoma progression by promoting intramitochondrial protein aggregation through mitoRQC. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.216895
Vancouver
Li G, Wang Z, Gao B, Dai K, Niu X, Li X, et al. ANKZF1 knockdown inhibits glioblastoma progression by promoting intramitochondrial protein aggregation through mitoRQC. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.216895
BibTeX
@article{Li2024,
author = {Li, Guangzhao and Wang, Zongqi and Gao, Bixi and Dai, Kun and Niu, Xiaowang and Li, Xiang and Wang, Yunjiang and Li, Longyuan and Wu, Xin and Li, Haiying and Yu, Zhengquan and Wang, Zhong and Chen, Gang},
title = {ANKZF1 knockdown inhibits glioblastoma progression by promoting intramitochondrial protein aggregation through mitoRQC},
journal = {Cancer Letters},
year = {2024},
doi = {10.1016/j.canlet.2024.216895}
}
EUVIMED